DOSSIER · 13F Holders · Q1 2026Healthcare · Pharmaceutical PreparationsHigh-convictionMulti-bagger
REGN
REGENERON PHARMACEUTICALS
1,457 institutions still hold REGENERON PHARMACEUTICALS as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 75886F107·Pharmaceutical Preparations·1,457 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
1,457 institutions reported REGN in Q1 2026. BlackRock, Inc. leads at 16.7% of the visible book. +9 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 73
1437 more holders available. Log in →